MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 10-23-2025
Medpace Holdings EV/EBITDA Ratio 2011-2025 | MEDP
Annual EV/EBITDA Ratio Medpace Holdings
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 30.7 | 23.9 | 20.1 | 16.6 | 14.9 | 12.2 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 30.7 | 12.2 | 19.8 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M |  USA |
 |
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M |  Israel |
 |
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | USA |
 |
DexCom
DXCM
|
39.5 | $ 64.79 | 2.0 % | $ 25 B | USA |
 |
Brainsway Ltd.
BWAY
|
-43.6 | $ 17.23 | 1.5 % | $ 99.4 M | Israel |
 |
Burning Rock Biotech Limited
BNR
|
-1.51 | $ 21.15 | 11.37 % | $ 233 M |  China |
 |
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-20.8 | $ 101.24 | 0.04 % | $ 18.8 B | USA |
 |
Biomerica
BMRA
|
-6.24 | $ 2.31 | 2.01 % | $ 5.31 M | USA |
 |
BioNano Genomics
BNGO
|
-7.71 | $ 1.69 | -1.74 % | $ 2.15 M | USA |
 |
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
3.62 | $ 0.36 | -0.39 % | $ 10.6 M | USA |
 |
Guardant Health
GH
|
-28.8 | $ 104.81 | -0.39 % | $ 12.9 B | USA |
 |
Celcuity
CELC
|
-2.38 | $ 98.24 | -0.25 % | $ 3.88 B | USA |
 |
DarioHealth Corp.
DRIO
|
-1.05 | $ 11.75 | -0.47 % | $ 333 M | Israel |
 |
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | USA |
 |
ICON Public Limited Company
ICLR
|
38 | $ 185.09 | 2.99 % | $ 15.3 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
45.3 | $ 733.11 | 0.57 % | $ 60.5 B | USA |
 |
Danaher Corporation
DHR
|
20.1 | $ 228.08 | 1.74 % | $ 167 B | USA |
 |
Illumina
ILMN
|
70.5 | $ 128.88 | 0.12 % | $ 20.5 B | USA |
 |
Anixa Biosciences
ANIX
|
-2.25 | $ 4.25 | -3.41 % | $ 136 K | USA |
 |
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 267.33 | -0.14 % | $ 22.4 B | USA |
 |
Lantheus Holdings
LNTH
|
-187 | $ 58.6 | -0.81 % | $ 4.06 B | USA |
 |
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | USA |
 |
Mettler-Toledo International
MTD
|
827 | $ 1 457.09 | -0.75 % | $ 30.9 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-17.2 | $ 7.06 | -0.03 % | $ 640 M | USA |
 |
ENDRA Life Sciences
NDRA
|
0.831 | $ 5.81 | -1.43 % | $ 3.12 M | USA |
 |
NeoGenomics
NEO
|
-33.5 | $ 12.02 | -0.04 % | $ 1.52 B | USA |
 |
Neogen Corporation
NEOG
|
40.3 | $ 5.91 | -0.25 % | $ 1.28 B | USA |
|
Biodesix
BDSX
|
-4.25 | $ 7.79 | - | $ 1.01 B | USA |
 |
National Research Corporation
NRC
|
21 | $ 16.27 | -3.1 % | $ 399 M | USA |
 |
Natera
NTRA
|
-19.5 | $ 237.72 | 1.48 % | $ 23.4 B | USA |
 |
Invitae Corporation
NVTA
|
-10.7 | - | - | $ 21.2 M | USA |
 |
Castle Biosciences
CSTL
|
-21.2 | $ 39.24 | 0.31 % | $ 1.09 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 184.06 | 0.16 % | $ 20.4 B | USA |
 |
Fulgent Genetics
FLGT
|
2.58 | $ 28.38 | -0.49 % | $ 858 M | USA |
 |
Organovo Holdings
ONVO
|
0.992 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
0.274 | - | -16.95 % | $ 1.54 M | USA |
 |
Pacific Biosciences of California
PACB
|
-23.8 | $ 2.33 | 4.69 % | $ 591 M | USA |
 |
PerkinElmer
PKI
|
18.8 | - | -0.91 % | $ 14.7 B | USA |
 |
Psychemedics Corporation
PMD
|
15.9 | - | -1.84 % | $ 15.3 M | USA |
 |
Precipio
PRPO
|
-1.8 | $ 24.56 | 8.81 % | $ 31.9 M | USA |
 |
Personalis
PSNL
|
-7.07 | $ 10.09 | 4.18 % | $ 598 M | USA |
 |
RadNet
RDNT
|
17.6 | $ 79.11 | -1.13 % | $ 5.78 B | USA |
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | China |